4//SEC Filing
Mond James 4
Accession 0001193805-21-000292
CIK 0001368514other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:01 PM ET
Size
8.3 KB
Accession
0001193805-21-000292
Insider Transaction Report
Form 4
Mond James
CSO/CMO
Transactions
- Award
Common Stock
2021-02-25+64,361→ 137,535 total - Award
Employee Stock Option (right to buy)
2021-02-25+139,000→ 139,000 totalExercise: $2.35Exp: 2031-02-25→ Common Stock (139,000 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units ("RSUs"). Of these RSUs, 55,000 RSUs will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 9,361 RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date. The RSUs will be settled into common stock upon vesting.
- [F2]Includes (i) 64,361 RSUs granted on February 25, 2021 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; (ii) 40,000 RSUs granted on February 28, 2020, which vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (ii) 33,174 shares of common stock owned by the reporting person.
- [F3]The options vest over four years with 25% of the shares of Common Stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 25, 2025.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0001554537
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 9:01 PM ET
- Size
- 8.3 KB